Skip to main content

Hwang Angela's Form 4 filing

Pfizer Inc (PFE) · filed Nov 15, 2021

Accession no.
0001225208-21-013881
Filed
Nov 15, 2021
Trade date
Nov 12, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.30M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hwang AngelaCIK 0001725474Officer (Group President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 12, 2021Common StockSSaleDisposed−800$49.61−$39,68825,371Direct
Nov 12, 2021Common StockSSaleDisposed−3,412$49.62−$169,303.4421,959Direct
Nov 12, 2021Common StockSSaleDisposed−10,646$49.59−$527,935.1411,313Direct
Nov 12, 2021Common StockSSaleDisposed−11,312$49.60−$561,075.21Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 12, 2021Common StockILess common codeAcquired+18,098$49.73+$900,013.5433,576Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)